David Medical announced that Chen Zaiwei, the controlling shareholder and one of the actual controllers of the company, and Jiang Haotao signed a share transfer agreement on September 21, 2026. Chen Zaiwei plans to transfer 14.4 million shares of the company's unlimited tradable shares at a price of 9.60 yuan/share, accounting for 5.00% of the company's total share capital, for a total transfer price of 138 million yuan. The transfer was registered on October 15, 2026. After the transfer, Chen Zaiwei's shareholding ratio dropped to 15.25%. Together with the co-actors, he held 61.06% of the shares, and Jiang Haotao held 5.00% of the shares, making him the shareholder holding more than 5% of the company's shares. This transfer does not involve an offer acquisition, does not constitute a related transaction, and will not result in a change in the controlling shareholder or actual controller of the company. Jiang Haotao promised not to reduce his holdings of the transferred shares for 12 months from the date the transfer was completed.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.